CNPFX
Price
$72.50
Change
-$0.41 (-0.56%)
Updated
Oct 7 closing price
Net Assets
164.4B
LSGGX
Price
$25.60
Change
-$0.18 (-0.70%)
Updated
Oct 7 closing price
Net Assets
143.46M
Interact to see
Advertisement

CNPFX vs LSGGX

Header iconCNPFX vs LSGGX Comparison
Open Charts CNPFX vs LSGGXBanner chart's image
American Funds New Perspective 529F
Price$72.50
Change-$0.41 (-0.56%)
VolumeN/A
Net Assets164.4B
Loomis Sayles Global Growth Y
Price$25.60
Change-$0.18 (-0.70%)
VolumeN/A
Net Assets143.46M
CNPFX vs LSGGX Comparison Chart in %
View a ticker or compare two or three
VS
CNPFX vs. LSGGX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPFX is a Hold and LSGGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPFX has more cash in the bank: 164B vs. LSGGX (143M). CNPFX pays higher dividends than LSGGX: CNPFX (0.62) vs LSGGX (0.00). CNPFX was incepted earlier than LSGGX: CNPFX (23 years) vs LSGGX (10 years). LSGGX (1.13) is less costly to investors than CNPFX (0.84). CNPFX is a more actively managed with annual turnover of: 24.00 vs. LSGGX (6.00). CNPFX has a lower initial minimum investment than LSGGX: CNPFX (250) vs LSGGX (100000). LSGGX annual gain was more profitable for investors over the last year : 27.56 vs. CNPFX (13.98). LSGGX return over 5 years is better than : 44.34 vs. CNPFX (38.24).
CNPFXLSGGXCNPFX / LSGGX
Total Expense Ratio0.840.9588%
Annual Report Gross Expense Ratio0.841.1374%
Fund Existence23 years10 years-
Gain YTD19.44023.17284%
Front LoadN/AN/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets164B143M114,685%
Annual Yield % from dividends0.620.00-
Returns for 1 year13.9827.5651%
Returns for 3 years65.28101.2564%
Returns for 5 years38.2444.3486%
Returns for 10 years112.39N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MAPIX17.18N/A
N/A
Matthews Asia Dividend Investor
ITHSX57.86N/A
N/A
Hartford Capital Appreciation R4
SHPCX13.51N/A
N/A
Saratoga Health & Biotechnology C
IUESX30.91N/A
N/A
JPMorgan International Focus I
SCSIX43.50N/A
N/A
Sterling Capital SmCp Val R6